Roche Bolster’s India’s fight against diabetes

Roche Diabetes Care India (Roche) has collaborated with public and private stakeholders in the Indian healthcare system to extend its commitment to improve access to care. This included enhancing education and awareness about diabetes and facilitating early diagnosis and sustained care programmes through transformative collaborations with key stakeholders.

The current doctor to patient ratio in India is at 1:8341, and to bolster this healthy ratio there is a need for capacity building of healthcare professionals. Addressing this critical factor in improving access to care, Roche undertook on-ground initiatives to enhance education, awareness and screening of diabetes within the healthcare ecosystem. These initiatives, in collaboration with both public and private stakeholders, touched the lives of more than 5,000 healthcare professionals and patients across the country in the last month. Collectively, these will help upskill healthcare professionals in the country and aid in early detection, thereby, providing sustained and significant support to those diagnosed with diabetes.

First among these initiatives was the ‘Nurses on Diabetes’ initiative, a revolutionary online education platform in partnership with Endocrine & Diabetes Foundation (EDF). This platform provides healthcare providers, particularly nurses, with the necessary skills to effectively manage diabetes and provide e-health coaching, incorporating health coaching principles alongside basic diabetes teachings. Upon finishing the programme, participants are awarded a certificate of completion. So far, this programme has been launched at 4 hospitals across Maharashtra and has already received 230 registrations. The team plans to take it to other cities including Kolkata, Chennai and Bangalore by the end of this year.

Roche has also partnered with Maharashtra State Government with the aim to bridge the gap in healthcare accessibility for underserved communities by bringing essential medical services directly to them. Starting November 23, Roche is supporting Maharashtra's National Health Mission (NHM) in organising multiple diabetes awareness and screening camps in Thane district on a massive scale under the central government’s 'Ayushman Bhav' campaign. These camps located at numerous local government hospitals including SDH Ambarnath, Central Hospital Ulhasnagar, Government Hospital Malvani, Pandit Bhimsen Joshi Hospital Mira Bhayandar, Maternity Home Ulhasnagar, and SDH Bhivandi, focused on early detection, prevention, and awareness about diabetes management and overall well being, contribute to the overall improvement of community health. By the end of November 2023, three of these camps have successfully facilitated the screening of 1500 people for diabetes.

This partnership was also extended to doctors and diabetes clinics through ~230 Doctor Support Centres (DSC) organised across the country. Through these DSC’s Roche team created direct engagement with diabetes nurse educators and more than 3000 people with diabetes to educate them about the need and benefits of structured self-monitoring of blood glucose (SMBG) which is the simplest and possibly the most practical tool to ensure glycaemic control. This initiative not only educates the patient on the convenience of SMBG but the data generated through regular SMBG also empowers HCPs to make adjustments in their therapeutic regimen in response to blood glucose values and regulate the dietary intake, physical activity, and insulin doses to improve glycaemic control on a regular basis.

Omar Sherief Mohammad, cluster head – India Middle East and Africa, RDC said, “Access to diabetes care begins with the right knowledge about diabetes and its management. The second step is to enable wide-spread and regular testing to facilitate early diagnosis. Lastly a sustained programme is required to ensure continued support is provided to those diagnosed with diabetes.”

“We believe that a concerted effort through private-public partnerships can aid in the country’s fight against diabetes. We are proud to partner the government and private healthcare practitioners in this drive to make India the Diabetes Care Capital of the World”, he added.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!